Profil
Jean-Yves Blay is currently an Independent Director at Transgene SA since 2022 and General Director at Centre Léon Bérard Lyon et Rhône-Alpes since 2014.
Former positions include Independent Member-Supervisory Board at Innate Pharma SA from 2017 to 2025, President of the European Organisation for Research & Treatment of Cancer from 2009 to 2012, Secretary of the Oncology Commission at Académie Nationale de Médecine FCP, and President of UNICANCER from 2019 to 2022.
Education includes a doctorate from Université Claude Bernard Lyon 1, conferred in 1994.
Aktive Positionen von Jean-Yves Blay
| Unternehmen | Position | Beginn |
|---|---|---|
| TRANSGENE | Direktor/Vorstandsmitglied | 25.05.2022 |
Centre Léon Bérard Lyon et Rhône-Alpes | Vorstandsvorsitzender | 01.01.2014 |
Ehemalige bekannte Positionen von Jean-Yves Blay
| Unternehmen | Position | Ende |
|---|---|---|
| INNATE PHARMA | Direktor/Vorstandsmitglied | 22.05.2025 |
UNICANCER
UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center | Präsident | 01.01.2022 |
European Organisation for Research & Treatment of Cancer
European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | Präsident | 01.01.2012 |
Académie Nationale de Médecine FCP
Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine | Corporate Officer/Principal | - |
Ausbildung von Jean-Yves Blay
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Université Claude Bernard Lyon 1
Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centre Léon Bérard Lyon et Rhône-Alpes | |
European Organisation for Research & Treatment of Cancer
European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | Commercial Services |
Académie Nationale de Médecine FCP
Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine | Commercial Services |
UNICANCER
UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center | Health Services |
















